BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
|
The Current P/S Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is 4.86.
Share Price | ₹29.8 | Apr 16,2024 |
Market Cap | ₹128.8 Cr | |
Sales-TTM | ₹26.5 Cr | TTM-Standalone Results |
Price/Sales | 4.86x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹128.8 Cr] as on Apr 16,2024
(/) Sales [ ₹26.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.86x ]
Thus, for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION , the investors are currently willing to pay '4.86 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION !
The chart below summarizes the trend in P/S Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION over the last five years.
Historical PS (Price/Sales) ratio chart of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
PS Ratio Performance Analysis for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.36x.
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's operated at median p/e ratio of 1.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio peaked in Mar2021 at 2.3x.
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio hit its five-year low in Mar2020 of 0.38x.
How does BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | 26.5 | 4.86 | 128.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.77 | 368,766.0 |
CIPLA LTD | 25,350.2 | 4.38 | 111,102.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.71 | 100,958.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.00 | 95,104.2 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.34 | 99,939.6 |
MANKIND PHARMA LTD | 9,946.3 | 9.19 | 91,420.3 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.20 | 85,851.8 |
LUPIN LTD | 19,480.1 | 3.76 | 73,329.7 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.33 | 65,027.5 |
ABBOTT INDIA LTD | 5,753.4 | 9.64 | 55,442.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.33x |
Max industry PS | 13.34x |
Median industry PS | 5.00x |
Average industry PS | 6.56x |
You may also like the below Video Courses